Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue Clinical Trials

12 clinical trials for Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Prognostic and predictive cytogenetic variants in hematological neoplasia — RECRUITING
Multimodal Early Detection of CAR T-Cell-Associated Neurotoxicity — RECRUITING
Retrospective evaluation of abdominal MRI imaging: prognostic value and therapy monitoring in patients with pancreatic neuroendocrine tumors receiving capecitabine and temozolomide (Cap/Tem) therapy — RECRUITING
Prospective study to the pathogenesis of osteoporosis in patients with indolent systemic mastocytosis — RECRUITING
Stay in the Game – Structured Trampoline Exercise During Pediatric Hematopoietic Stem Cell Transplantation — OTHER
Weight Development in Children Undergoing Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Analysis — OTHER
Cross-Sectoral Care of Patients with Hematologic Diseases After Innovative Cell Therapy — OTHER
Development and validation of a questionnaire to measure medication literacy in patients receiving oral anticancer drugs — OTHER
Acute effects of mental fatigue on gait performance and prefrontal oxygenation in haematological and oncological patients as a function of cancer-related fatigue — OTHER
Sports practiced, fears and adverse events during sports in patients with myeloproliferative neoplasms — OTHER
Patient information, communication and competence empowerment in oncology — OTHER
Risk-stratified sequential treatment of post-transplant lymphoproliferative disease (PTLD) with 4 courses of rituximab SC followed by 4 courses of rituximab SC, 4 courses of rituximab SC combined with CHOP-21 or 6 courses of rituximab SC combined with alternating CHOP-21 and DHAOx: The PTLD-2 trial — OTHER

Refine this search